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ABSTRACT
Although radon therapy is indicated for hyperuricemia, the underlying mechanisms of action have not yet been elu-
cidated in detail. Therefore, we herein examined the inhibitory effects of radon inhalation and hot spring water
drinking on potassium oxonate (PO)–induced hyperuricemia in mice. Mice inhaled radon at a concentration of
2000 Bq/m3 for 24 h or were given hot spring water for 2 weeks. Mice were then administrated PO at a dose of
500 mg/kg. The results obtained showed that serum uric acid levels were signiﬁcantly increased by the administra-
tion of PO. Radon inhalation or hot spring water drinking signiﬁcantly inhibited elevations in serum uric acid
levels through the suppression of xanthine oxidase activity in the liver. Radon inhalation activated anti-oxidative
functions in the liver and kidney. These results suggest that radon inhalation inhibits PO-induced hyperuricemia
by activating anti-oxidative functions, while hot spring water drinking may suppress PO-induced elevations in
serum uric acid levels through the pharmacological effects of the chemical compositions dissolved in it.
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INTRODUCTION
Therapy using radon hot springs (222Rn) is performed for pain- or
respiratory-related diseases such as osteoarthritis [1] and bronchial
asthma [2] in the Misasa Medical Center, Okayama University Hos-
pital, Japan. Radon therapy is also performed in Europe, and spe-
leotherapy has been reported to have endocrinological effects on
respiratory diseases [3]. Although baths with low radon concentra-
tions were previously shown to have no inﬂuence on the function of
the endocrine system [4], radon therapy is known to be effective
against pain-related diseases. For example, a meta-analysis of con-
trolled clinical trials demonstrated the positive effects of radon
therapy on pain in rheumatic diseases [5].
Theoretically, animals absorb radon through the lungs and skin.
However, radon absorption through the skin has neither been
rejected nor conﬁrmed [3]. The mechanism of action of radon
therapy has been suggested to involve radon being taken into the
lungs via breathing, dissolving in the blood by gas exchange, being
transported to many tissues systemically through the bloodstream,
and having stimulatory effects in these tissues [6]. In an attempt to
elucidate the mechanism of action of radon therapy, we previously
developed a radon exposure system for small animals [7]. We subse-
quently demonstrated that radon inhalation induced the production
of anti-oxidant substances in many organs, such as the brain, heart,
lung, liver, pancreas, kidney and small intestine of mice [8], and also
inhibited carbon tetrachloride (CCl4)–induced hepatopathy and
renal damage [9]. These ﬁndings suggest that the anti-oxidative func-
tions induced by radon inhalation contribute to the mitigation of
reactive oxygen species (ROS)–related diseases.
Drinking treatments are effective against not only pain-related dis-
eases, but also against hyperuricemia due to their effects on purine
and uric acid metabolism, and that the pharmacological effects of che-
micals dissolved in hot spring water are much greater than from
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radon [10–13]. The concentrations of dissolved minerals (such as
sodium bicarbonate and carbonates) in European hot springs were
previously found to be 10-times higher than those in Japanese hot
springs; therefore, drinking treatments in Europe only require
approximately half of the volume needed in Japan [14]. However, the
mechanisms of action of these treatments, particularly those of radon
drinking treatments, currently remain unclear.
During the metabolism of purines, hypoxanthine and xanthine
are oxidized to uric acid by the enzyme xanthine oxidase (XOD)
[15, 16]. XOD is distributed in various cells [17], including not
only vascular cells [18, 19], but also the liver, which is one of the
major sources of ROS [20–23]. The liver and kidneys are exposed to
oxidative stress through increases in serum uric acid levels [24], and
hyperuricemia has been found to be inhibited by the administration
of anti-oxidants such as vitamin C [25].
The aim of the present study was to investigate and compare the
inhibitory effects of radon inhalation and hot spring water drinking
treatments on potassium oxonate (PO)–induced hyperuricemia. We
focused on PO-induced oxidative stress because, as described above,
the liver and kidneys are exposed to oxidative stress through increases
in serum uric acid levels. We examined the following biochemical
parameters in order to assess the effects of radon treatments: serum
uric acid levels, XOD activity in the liver, superoxide dismutase
(SOD) activity, catalase (CAT) activity, and total glutathione content
(t-GSH) in the liver and kidneys.
MATERIALS AND METHODS
Animals
Male ICR mice (8 weeks of age, body weight 32–38 g) were obtained
from Charles River Laboratories Japan Inc. (Yokohama, Japan) for
the radon inhalation treatment and from CLEA Japan Inc. (Tokyo,
Japan) for the water drinking treatment. They were maintained in
plastic cages under controlled conditions of temperature (22 ± 2°C),
humidity (55 ± 10%), and light (12 h of light, 12 h of dark), and were
given free access to food and water. Ethics approval for all protocols
and experiments was obtained from the Animal Experimental Com-
mittee of Okayama University.
Experimental procedure
Induction of hyperuricemia
An animal model of hyperuricemia was induced by PO, a urate
oxidase (uricase) inhibitor, because the PO model of hyperuricemia
is widely perceived as a good experimental model. Brieﬂy, mice were
intraperitoneally injected with PO (500 mg/kg body weight; Wako
Pure Chemical Industry Co. Ltd, Osaka, Japan) after the radon inhal-
ation or hot spring water drinking treatment. PO was suspended in
0.5% sodium carboxymethylcellulose (CMC-Na; Azuwann Co. Ltd,
Osaka, Japan), which was freshly prepared before its administration.
Control mice were manipulated in parallel with a 0.5% CMC-Na
injection.
Hot spring water drinking treatment
Mice were randomly divided into the following nine groups based on
the treatments and time-courses (n = 8–9 for each group): distilled
water drinking only (DW), radon-containing hot spring water drink-
ing only (Water with Rn), radon-deaeration hot spring water drinking
only (Water without Rn), distilled water drinking with the administra-
tion of PO (DW+PO), Rn-containing hot spring water drinking with
the administration of PO (Water with Rn+PO) and Rn-deaeration
hot spring water drinking with the administration of PO (Water
without Rn+PO). Mice were continuously fed distilled water, hot
spring water containing radon, or radon deaeration hot spring
water (from which radon was removed) for 2 weeks. Radon-contain-
ing hot spring water was obtained from the Misasa Medical Center,
Okayama University Hospital, with attention to the water foaming
and dissipation of radon. Radon-deaeration hot spring water was
obtained by bubbling Rn-containing hot spring water using an air
pump for ∼20 min to dissipate radon. After 2–3 days of storage, hot
spring water was supplied to mice at room temperature. Drinking
water was replaced three times a week.
The pH of hot spring water was ∼7.0–7.3. Table 1 shows the princi-
pal chemical compositions of hot spring water for the drinking treat-
ment. The radon concentration in water was measured using a liquid
scintillation counter. The radon concentration in and drinking volume
of water were monitored continuously at 2- or 3-day intervals (Table 2).
Mean radon concentrations in Rn-containing hot spring water and Rn-
deaeration hot spring water were 338 ± 11 Bq/l and 1.8 ± 0.4 Bq/l,
respectively, at the initiation of the treatments (Table 2).
After the drinking treatments, hyperuricemia was induced in mice
via the intraperitoneal (i.p.) administration of a single dose of PO (500
mg/kg body weight) in CMC-Na. Mice were sacriﬁced by an overdose
of ether anesthesia 1.5 and 3 h after the administration of PO. Blood
was drawn from the heart for a serum analysis, and the livers and
kidney were surgically excised and rinsed in 10 mM phosphate buffered
saline (PBS; pH 7.4) buffer to analyze the activities of XOD, SOD and
CAT, and the levels of t-GSH and proteins. Serum was separated by
centrifugation at 3000 × g for 5 min for the uric acid assay. Samples
were preserved at –80°C for later biochemical analyses.
Radon inhalation treatment
Mice were randomly divided into three groups (n = 6 for each
group): sham inhalation only (Control), sham inhalation with the
administration of PO only (PO), and radon inhalation with the
administration of PO (Rn+PO). Mice were exposed to air only or
radon for 24 h (using the radon exposure system we previously
developed) and fed normal drinking water. Brieﬂy, radon at a
Table 1. Principal chemical compositions of drinking water
Element
Fe Mn Cr Cu Zn Cd Pb As Se Sb B Al Ni
0.11 <0.01 <0.005 0.024 0.011 <0.005 <0.005 0.29 <0.005 <0.005 1.6 <0.005 <0.005
All values are in milligrams per liter.
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concentration of 2000 Bq/m3 was blown into a mouse cage [26]).
The radon concentration in the cages was then determined by refer-
ence to radon therapy at the Misasa Medical Center, Okayama Uni-
versity Hospital [1, 2]. Radon concentrations were measured using a
radon monitor (CMR-510; Femto-Tech Inc., Carlisle, OH, USA).
Radon concentrations in mouse cages are shown in Fig. 1. The
mean radon concentrations achieved by the inhalation treatments
were ∼2000 Bq/m3 (Fig. 1).
Hyperuricemia was induced in mice after inhalation by the same
method as that for the drinking treatment experiment. Blood was
drawn from the heart 3 h after the administration of PO for a serum
analysis, the livers and kidneys were surgically excised, and specimens
were treated using similar procedures to those described for the
drinking treatment experiment. Samples were preserved at –80°C for
later biochemical analyses. Samples were obtained from mice treated
without PO immediately after inhalation, using the same procedures.
Biochemical assays
Serum uric acid levels were measured according to Takagi’s modiﬁca-
tion of the phosphotungstic acid method described by Caraway et al.
[27]. Brieﬂy, serum was deproteinized by a mixture of
phosphotungstic acid and sodium hydroxide solutions and centri-
fuged at 3000 × g at 4°C for 5 min. Deproteinized serum was col-
lected, mixed with phosphotungstic acid and sodium carbonate
solutions, and then incubated at 25°C for 25 min. The optical density
of the colored product, tungsten blue, was read at 710 nm using a
spectrophotometer. All reagents and chemicals used for the uric acid
assay were from Wako Pure Chemical Industries Co. Ltd (Osaka,
Japan).
XOD activity in the liver was measured using the Xanthine Oxidase
Activity Colorimetric/Fluorometric Assay Kit (BioVision Inc., Milpitas,
CA, USA) according to the manufacturer’s recommendations. Brieﬂy,
the liver was homogenized in XOD assay buffer and the homogenate
was centrifuged at 16 000 × g at 4°C for 10 min in order to obtain a clear
XOD extract. Supernatants were collected, mixed with the XOD enzyme
mix, substrate mix, OxiRed™ Probe, and reaction mix, and the absorb-
ance was then read at 570 nm using a spectrophotometer at 10-min
intervals by incubating at 25°C for 30 min. In the XOD assay, protein
concentrations were measured using the Lowry method with the Bio-
Rad DC protein assay kit (Bio-Rad Laboratories Inc., Tokyo, Japan).
Livers and kidneys were homogenized on ice in 10 mM PBS. The
homogenates were centrifuged at 12 000 × g at 4°C for 45 min and
the supernatants were used to measure SOD and CAT activities.
SOD activity was measured by the nitroblue tetrazolium (NBT)
reduction method [28] using the Wako-SOD test (Wako Pure Chem-
ical Industry Co. Ltd, Osaka, Japan) according to the manufacturer’s
recommendations. Brieﬂy, inhibition of the reduction of NBT was
measured at 560 nm using a spectrophotometer. One unit of enzyme
activity was deﬁned as 50% inhibition of NBT reduction.
CAT activity was measured as the rate of hydrogen peroxide
(H2O2) reduction at 37°C at 240 nm using a spectrophotometer
[29]. The assay mixture consisted of 50 μl of 1 M Tris (tris-hydroxy-
methyl-aminomethane)-HCl buffer containing 5 mM ethylenediami-
netetraacetic acid (pH 7.4), 900 μl of 10 mM H2O2, 30 μl of
deionized water, and 20 μl of the supernatant. CAT activity was calcu-
lated using a molar extinction coefﬁcient of 7.1 × 10−3 M−1cm−1.
The t-GSH content was measured using the Bioxytech GSH-420
assay kit (Oxis Health Products Inc., Portland, OR, USA) according
to the manufacturer’s recommendations. Brieﬂy, liver and kidney
samples were suspended in 10 mM PBS, and mixed with an ice-cold
7.5% trichloroacetic acid solution and homogenized. The homoge-
nates were centrifuged at 3000 × g for 10 min. The supernatants were
then used in the assay.
Protein concentrations were measured using the Bradford method
[30] with the Protein Quantiﬁcation Kit-Rapid (Dojindo Molecular
Technologies Inc., Kumamoto, Japan).
Statistical analysis
Data are presented as the mean ± standard error of the mean (SEM).
Each experimental group consisted of samples from six to nine
animals. The signiﬁcance of differences was determined by using
Tukey’s test and Dunnet’s test for multiple comparisons. P < 0.05 was
considered signiﬁcant.
RESULTS
Changes in drinking volume
No signiﬁcant differences were observed in drinking volumes
throughout the experimental period between any of the treatment
groups (Table 2).
Fig. 1. Changes in radon concentrations in the mouse cage
over the period of radon inhalation using a radon inhalation
system.
Table 2. Radon concentrations in hot spring water and
drinking volume
Parameters Rn-containing
hot spring
water
Rn-deaeration
hot spring water
Distilled
water
Concentrations
of water (Bq/l)
at the start point
of supplying
338 ± 11 1.8 ± 0.4
at the end point
of supplying
62 ± 2 N.D. N.D.
Drinking volume
(ml/day/capita)
2.85 ± 0.38 2.32 ± 0.33 2.26 ± 0.18
N.D. = not detected.
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Effects of hot spring water drinking on PO-induced
hyperuricemia
Serum uric acid levels were signiﬁcantly higher (P < 0.01) in the DW
+PO group than in the DW group 1.5 h after the administration of PO,
whereas no signiﬁcant differences were noted between the DW+PO
group and the other groups (Water with Rn+PO or Water without Rn
+PO groups). Serum uric acid levels were signiﬁcantly higher (P < 0.001)
in the DW+PO group than in the DW group 3 h after the administration
of PO. However, serum uric acid levels were slightly lower in the Water
with Rn+PO and Water without Rn+PO groups (Fig. 2).
Effects of hot spring water drinking on XOD activity
in mice with PO-induced hyperuricemia
XOD activity in the liver was higher in the DW+PO group than in the
DW group 1.5 h after the administration of PO; however, no signiﬁcant
differences were observed between the DW+PO group and the other
groups (Water with Rn+PO or Water without Rn+PO groups). XOD
activity in the liver was signiﬁcantly higher (P < 0.05) in the DW+PO
group than in the DW group 3 h after the administration of PO.
However, XOD activity in liver was signiﬁcantly lower (P < 0.05) in the
Water with Rn+PO group than in the DW+PO group (Fig. 2).
Effects of hot spring water drinking on antioxidant-
associated substances in the liver and kidney of mice with
PO-induced hyperuricemia
SOD activity in the liver at 3 h after the administration of PO was sig-
niﬁcantly higher (P < 0.05) in the Water without Rn+PO group than
in the Water with Rn+PO group. The t-GSH content in the liver at
1.5 h after the administration of PO was signiﬁcantly lower (P < 0.05)
in the Water without Rn+PO group than in the Water with Rn+PO
group. Furthermore, t-GSH content in the DW+PO group was sig-
niﬁcantly lower (P < 0.05) at 3 h after the administration of PO than
that of the group at 1.5 h after the administration of PO; however, no
signiﬁcant differences were noted between the DW+PO group and
the other groups (Water with Rn+PO or Water without Rn+PO
groups). In addition, the t-GSH content in the Water with Rn+PO
group was signiﬁcantly lower at 3 h after the administration of PO than
that in the Water with Rn group (P < 0.01) and signiﬁcantly lower
(P < 0.01) than that of the Rn+PO group at 1.5 h after the administra-
tion of PO (P < 0.001). SOD activity in the kidney was signiﬁcantly
lower (P < 0.001) in the DW+PO group 1.5 and 3 h after the admin-
istration of PO than in the DW group. However, it was signiﬁcantly
higher in the Water with Rn+PO (1.5 h: P < 0.01, 3 h: P < 0.001) and
in the Water without Rn+PO (P < 0.001) groups than in the DW
+PO group. Furthermore, at 3 h after the administration of PO, it was
signiﬁcantly higher (P < 0.01) in the Water without Rn+PO group
than in the Water with Rn+PO group. In addition, SOD activity in
the Water with Rn+PO group was signiﬁcantly lower (P < 0.05) at 3
h after the administration of PO than in the Water with Rn group.
CAT activity in the kidney was signiﬁcantly lower (P < 0.05) in the
DW+PO group than in the DW group 3 h after the administration of
PO; however, no signiﬁcant differences were noted between the DW
+PO group and the other groups (Water with Rn+PO or Water
without Rn+PO groups). In addition, at 3 h after the administration
of PO, CAT activity was signiﬁcantly lower (P < 0.05) in the Water
with/without Rn+PO groups than in the Water with/without Rn
groups. The t-GSH content in the kidney was signiﬁcantly lower (P <
0.05) at 3 h after the administration of PO in the Water with Rn+PO
group than in Water with Rn and that of the group at 1.5 h after the
administration of PO (Fig. 3).
Effects of radon inhalation on PO-induced hyperuricemia
Since serum uric acid levels were higher in mice 3 h after the adminis-
tration of PO than 1.5 h after, the former were subsequently used in
radon inhalation experiments.
Serum uric acid levels were signiﬁcantly higher (P < 0.001) in the
PO group than in the Control group. However, they were signiﬁcantly
lower (P < 0.05) in the Rn+PO group than in the PO group (Fig. 4).
Effects of radon inhalation on XOD activity in mice
with PO-induced hyperuricemia
XOD activity in the liver was higher in the PO group than in the
Control group, and was lower in the Rn+PO group than in the PO
group (Fig. 4).
Fig. 2. Effects of drinking hot spring water on serum uric acid levels and xanthine oxidase (XOD) activity in the liver of mice
with potassium oxonate (PO)–induced hyperuricemia. Each value is the mean ± SEM. The number of mice per experimental
point is 8–9. *P < 0.05, **P < 0.01, ***P < 0.001, distilled water (DW) drinking with the administration of PO vs DW drinking
only. #P < 0.05, Rn-containing hot spring water (Water with Rn) drinking with the administration of PO, or Rn-deaeration hot
spring water (Water without Rn) drinking with the administration of PO vs DW drinking with the administration of PO.
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Effects of radon inhalation on antioxidant-associated
substances in the liver and kidney of mice
with PO-induced hyperuricemia
SOD and CAT activities and t-GSH content in the liver and kidney
were lower in the PO group than in the control group. SOD activity
(P < 0.05) and t-GSH content (P < 0.05) in the liver were signiﬁcantly
higher in the Rn+PO group than in the PO group. No signiﬁcant differ-
ences were observed in CAT activity in the liver among these groups.
SOD activity and t-GSH content in the kidney were signiﬁcantly
higher (P < 0.05) in the Rn+PO group than in the PO group. No sig-
niﬁcant differences were detected in CAT activity in the kidney
between these groups (Fig. 5).
Fig. 3. Effects of drinking hot spring water on antioxidant-associated substances in the liver and kidney of mice with potassium
oxonate–induced hyperuricemia. The data and number of mice are as described in Fig. 2. *P < 0.05, ***P < 0.001, distilled water
(DW) drinking with the administration of PO vs DW drinking only. ##P < 0.01, ###P < 0.001, Rn-containing hot spring water
(Water with Rn) drinking with the administration of PO, or Rn-deaeration hot spring water (Water without Rn) drinking with
the administration of PO vs DW drinking with the administration of PO. ¶¶P < 0.01, distilled water (DW) drinking with the
administration of PO at 3 h after administration vs distilled water (DW) drinking with the administration of PO at 1.5 h after
administration. ‡P < 0.05, ‡‡P < 0.01, Rn-containing hot spring water (Water with Rn) drinking with the administration of
PO at 3 h after administration vs Rn-containing hot spring water (Water with Rn) drinking only. §P < 0.05, §§§P < 0.001,
Rn-containing hot spring water (Water with Rn) drinking with the administration of PO at 3 h after administration vs
Rn-containing hot spring water (Water with Rn) drinking with the administration of PO at 1.5 h after administration.
||P < 0.05, Rn-deaeration hot spring water (Water without Rn) drinking with the administration of PO at 3 h after administration
vs Rn-deaeration hot spring water (Water without Rn) drinking only. +P < 0.05, ++P < 0.01, Rn-deaeration hot spring water
(Water without Rn) drinking with the administration of PO vs Rn-containing hot spring water (Water with Rn) drinking with
the administration of PO.
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DISCUSSION
Radon inhalation activates anti-oxidative functions in various organs,
such as the brain, heart, lung, liver, pancreas and kidneys in mice and,
thus, may contribute to the inhibition of oxidative stress-related
diseases in these organs [8]. We previously demonstrated that radon
inhalation protected tissues from chemically induced oxidative
damage [9, 31], indicating that radon inhalation activates a biological
defense system in mouse tissues that inhibits oxidative stress-related
Fig. 4. Effects of radon inhalation on serum uric acid levels and xanthine oxidase (XOD) activity in the liver of mice with potassium
oxonate–induced hyperuricemia. Each value is the mean ± SEM. The number of mice per experimental point was six. ***P < 0.001,
sham inhalation with the administration of PO vs control, #P < 0.05 radon inhalation with the administration of PO vs PO alone.
Fig. 5. Effects of radon inhalation on antioxidant-associated substances in the liver and kidney of mice with potassium oxonate–
induced hyperuricemia. The data and number of mice are as described in Fig. 4. #P < 0.05 radon inhalation with the
administration of PO vs PO.
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diseases. However, the mechanisms of action of radon inhalation and
hot spring water drinking on hyperuricemia currently remain unclear.
Therefore, we herein examined the effects of radon inhalation and
hot spring water drinking on PO-induced hyperuricemia. The results
obtained showed that the administration of PO elevated serum uric
acid levels. With the inhalation treatments, serum uric acid levels were
signiﬁcantly lower in the Rn+PO group than in the PO group. With
the drinking treatments, serum uric acid levels were slightly lower in
the Water with Rn+PO and Water without Rn+PO groups than
in the DW+PO group. Furthermore, no signiﬁcant differences were
observed in the volume of water consumption between any of the
groups. Therefore, radon inhalation or water with/without radon
drinking suppressed PO-induced hyperuricemia. These are probably
due to the pharmacological effects of chemical compositions dis-
solved in hot spring water are much greater than the those of radon,
because serum uric acid levels were similar between mice treated with
Water with Rn and those treated with Water without Rn.
In an attempt to clarify the mechanisms suppressing hyperurice-
mia, XOD activity in the liver and antioxidant substances were investi-
gated. Excessive elevations in serum uric acid levels have been shown
to produce ROS and oxidative damage [24, 32], which further
increases xanthine and hypoxanthine levels as well as XOD activity in
the liver. During the metabolism of purines, the production of ROS
such as the superoxide radical (O2
•–) and H2O2 occurs through the
formation of metabolic by-products from the oxidation of hypoxan-
thine and xanthine to uric acid by XOD [33]. Therefore, an increase
in ROS or XOD activity contributes to elevations in uric acid levels.
SOD plays an important role in protecting cells from oxidative
damage by converting O2
•– into H2O2. CAT transforms H2O2 into
H2O as well as GSH. Our results showed that the administration of
PO increased XOD activity in the liver, which may have, in turn,
enhanced oxidative stress and suppressed anti-oxidative functions.
Radon inhalation decreased XOD activity in the liver, indicating the
inhibition of uric acid biosynthesis. SOD activity and the t-GSH
content in the liver and kidney were signiﬁcantly higher in the Rn
+PO group than in the PO group, suggesting that radon inhalation
suppresses PO-induced hyperuricemia by enhancing anti-oxidative
functions and inhibiting uric acid biosynthesis in the liver. In the case
of the drinking treatments, regardless of the suppression of XOD
activity, elevations in uric acid levels were suppressed in both groups
treated with water in the presence or absence of radon. Moreover,
even in the same organ or group, no certain tendency for increase or
decrease in the anti-oxidant-associated substances was observed to be
dependent on the presence or absence of radon. Previous studies
reported that drinking and bathing in hot spring water promotes the
excretion of uric acid in the urine. These ﬁndings indicate that various
compositions dissolved in hot spring water play an important role in
decreasing uric acid levels. However, further studies are needed in
order to clarify the involvement of these compositions.
Although XOD inhibitor drugs (e.g. allopurinol) that inhibit uric
acid biosynthesis or uricosuric drugs (e.g. benzbromarone) that
enhance the excretion of uric acid are typically used in the treatment
of patients with hyperuricemia [34, 35], allopurinol is the only XOD
inhibitor [36–38]. However, allopurinol causes side effects in some
patients with hepatic diseases, renal diseases, and allergic reactions
[39–42]. In the present study, we demonstrated that radon inhalation
or hot spring water drinking exerted the same effects as allopurinol.
Therefore, radon inhalation or hot spring water drinking may assist
the functions of allopurinol.
In conclusion, radon inhalation activated anti-oxidative functions
and inhibited XOD activity in the liver. As a result, radon inhalation
suppressed PO-induced elevations in serum uric acid levels via
respiratory organs. On the other hand, hot spring water drinking sup-
pressed PO-induced elevations in serum uric acid levels via digestive
organs. The pharmacological effects are probably much larger due to
the chemicals dissolved in hot spring water than from radon.
Radon therapy is performed for various diseases at the Misasa
Medical Center, Okayama University Hospital, Japan. However, the
mechanisms underlying the health effects achieved have not been
investigated in detail. Our results suggest the potential of radon
therapy for the prevention of hyperuricemia. Moreover, the mechan-
isms responsible for the inhibitory effects of radon inhalation and
drinking water on hyperuricemia may differ.
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